Chloroquine sensitivity of Plasmodium vivax in Thailand.
about
Primaquine for preventing relapses in people with Plasmodium vivax malariaPrimaquine in vivax malaria: an update and review on management issuesPrimaquine radical cure of Plasmodium vivax: a critical review of the literatureChloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms.Resistance to therapies for infection by Plasmodium vivaxPlasmodium vivax malaria endemicity in Indonesia in 2010.Directly-observed therapy (DOT) for the radical 14-day primaquine treatment of Plasmodium vivax malaria on the Thai-Myanmar borderMonitoring of clinical efficacy and in vitro sensitivity of Plasmodium vivax to chloroquine in area along Thai Myanmar border during 2009-2010.High-dose primaquine regimens against relapse of Plasmodium vivax malaria.The first Plasmodium vivax relapses of life are usually genetically homologousChloroquine resistance in Plasmodium vivax.Can treatment of P. vivax lead to a unexpected appearance of falciparum malaria?Clinical efficacy of chloroquine versus artemether-lumefantrine for Plasmodium vivax treatment in Thailand.Safety and tolerability of elubaquine (bulaquine, CDRI 80/53) for treatment of Plasmidium vivax malaria in ThailandTriangular test design to evaluate tinidazole in the prevention of Plasmodium vivax relapseAdherence to antimalarial drug therapy among vivax malaria patients in northern Thailand.Artemisinin or chloroquine for blood stage Plasmodium vivax malaria in Vietnam.Clinical-parasitological response and in-vitro sensitivity of Plasmodium vivax to chloroquine and quinine on the western border of Thailand.Efficacy of chloroquine in the treatment of Plasmodium vivax malaria in Turkey.Pharmacodynamics of antimalarial chemotherapy.Improved assessment of plasmodium vivax response to antimalarial drugs by a colorimetric double-site plasmodium lactate dehydrogenase antigen capture enzyme-linked immunosorbent assay.The decreasing efficacy of chloroquine in the treatment of Plasmodium vivax malaria, in Sanliurfa, south-eastern Turkey.
P2860
Q24246197-A87016BB-ADAD-4E5D-AF9B-A84E3BEB0494Q27003856-AC674C14-E6FF-40A2-97DE-34ED1C47B7A5Q27027939-835535EC-C325-4078-BF2A-35D11CA5AF14Q33304430-66155461-0AFF-4C5B-9D90-65D4CAA8EFBDQ33481576-E07915B0-2F8F-47E6-97E3-38E90616DBC4Q34277987-F493F4A2-7CDC-46AC-88AD-42978A23399FQ34332235-D5CA1035-6489-4064-88FF-539FACEEC46CQ34660024-3DDD7055-A5C4-462A-B885-B4463DF805E5Q35086211-EFF23E2D-25E7-4DEE-B87B-A0F2964D23CBQ35694709-CE54FB56-45F3-4B2A-9185-3052F41DAD23Q35927662-CE17BB06-FC27-40FE-905E-E5C4CC2CECB0Q36843969-59FF6371-DC5F-4734-83FE-C437DA919F58Q36853749-ADAEB793-191A-4927-BDCA-E57FCAF0CC38Q36868308-73ED505C-56C7-4FB4-B917-97F3D44D0954Q36898219-CBC2C03C-6259-4CAD-9A6A-66E0DA9FE75EQ37387179-2F3F5571-B777-4C31-8638-2E415EBE94ACQ39353584-C7B91F30-EAA1-426C-82CE-C50E46207892Q40485571-CCAE138B-99E9-40C7-9EE7-D39B93A74AB4Q41913728-94C8DB77-ECDC-4437-8BF1-90CA4F99E93DQ41937695-770FD9CC-C150-415B-8E42-DF104EF8937CQ41943311-CE0B2A25-68DE-4DD5-BC14-38B86A571D68Q41945848-045278CF-58DC-42D2-A429-F45DB0184240
P2860
Chloroquine sensitivity of Plasmodium vivax in Thailand.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Chloroquine sensitivity of Plasmodium vivax in Thailand.
@en
Chloroquine sensitivity of Plasmodium vivax in Thailand.
@nl
type
label
Chloroquine sensitivity of Plasmodium vivax in Thailand.
@en
Chloroquine sensitivity of Plasmodium vivax in Thailand.
@nl
prefLabel
Chloroquine sensitivity of Plasmodium vivax in Thailand.
@en
Chloroquine sensitivity of Plasmodium vivax in Thailand.
@nl
P2093
P921
P356
P1476
Chloroquine sensitivity of Plasmodium vivax in Thailand.
@en
P2093
Bussaratid V
Chalermrut K
Chokjindachai W
Krudsood S
Singhasivanon P
Treeprasertsuk S
Viriyavejakul P
P304
P356
10.1080/00034989958474
P577
1999-04-01T00:00:00Z